Congress programme PerMediCon 2012
Here, you can find the congress programme of PerMediCon 2012 as pdf-file ready for download.
Finde the congress programme of Wednesday, 20. June 2012 here.
Tuesday, 19th June 2012
(subject to changes)
| Time | |
|---|---|
| 09:30a.m. | Registration & Opening of the exhibition |
| 10:00a.m. | Opening and welcoming Introduction: Prof. Dr. Theo Dingermann, Chair for Pharmaceutical Biology, Goethe-University Frankfurt Welcoming: Gerald Böse, President, Chief Executive Officer, Koelnmesse GmbH Opening: Dr. Helge Braun, Parliamentary State Secretary to the Federal Minister of Education and Research |
| 10:30a.m. | Keynote: Personalized medicine: (How) Can different therapeutic areas learn from each other? Prof. Dr. Michael Hallek, Director Clinic I Department of Internal Medicine, University Hospital of Cologne |
| 11:00a.m. | Panel: Business Case Personalized medicine – what does a sustainable business model look like? Moderation: Prof. Dr. Theo Dingermann, Chair for Pharmaceutical Biology, Goethe-University Frankfurt Participants: Dr. Norbert Gerbsch, Deputy Director General, German Pharmaceutical Industry Association (BPI e.V.) Jörg-Michael Hollidt, Chairman of the Executive Board, Diagnostik-NetBB; CEO, in.vent Diagnostica GmbH Dr. Robert Lange, Managing director, hospital Laborverbund Brandenburg-Berlin GmbH Hardy Müller, Scientific Institute of TK for benefit and efficiency in health care Dr. Joachim Rautter, Managing partner, Peppermint VenturePartners GmbH |
| 12:00p.m. | Lunch, Networking & Visit of the exhibition |
| Innovation Fora | |||
|---|---|---|---|
| 02:00p.m. | Forum 1 | Forum 2 | Forum 3 |
| Innovation & Practice | Innovation & Practice | Framework conditions | |
| Status quo & perspectives of personalized medicine in the treatment of cancerous diseases Chair: Prof. Dr. Peter Lichter, Head of Divison Molecular Genetics, German Cancer Research Center Speakers: Prof. Dr. Reinhard Büttner, Professor and Chairman, Institute of Pathology, University Hospital Cologne Prof. Dr. Klaus-Michael Debatin, Chairman, Vice President Medicine Ulm University, Dept. of Pediatrics and Adolescent Medicine University Medical Center Ulm Prof. Dr. Christof von Kalle, Director, National Center for Tumor Diseases Heidelberg; Chair, Dept. of Translational Oncology, NCT at German Cancer Research Center (DKFZ) Dr. Franz Xaver Kohlhuber | Applications & potentials of health technologies for personalized medicine Chair: Prof. Dr. Kurt Becker, Head of Subdivision BVMI North Rhine-Westphalia, Director of Studies – Health Technology Management Apollon University of Health Management Bremen, CEO promedtheus AG Speakers: Dr. Dieter Beule, CTO, MicroDiscovery GmbH Dipl.-Kfm. Bernhard Calmer, Manager IT Sales, Siemens AG – Health Care Sector Dr. Jörg Kränzlein, Director Life Science, iSoft Health GmbH Prof. Dr. Otto Rienhoff, Director of Department of Medical Informatics, University Medical Center Göttingen Sebastian C. Semler, CEO / Scientific Management TMF e. V., TMF – Technologie- und Methodenplattform für die vernetzte medizinische Forschung e.V. | Governance of biobanks Chair: Dr. Thorsten Ruppert, Senior Manager Research/ Development/ Innovation, German Association of Research-based Pharmaceutical Companies Co-Chair: Dr. Christina Schröder, Head of Group „Biobank networks“, Fraunhofer Institute for Biomedical Engineering Speakers: PD Dr. Thomas Gerloff, Medical Science & Innovation; Exploratory Medicine, Merck Serono; Merck KGaA Germany PhD Michael Krawczak, Institute Director, Institute of Medical Informatics and Statistics, Christian - Albrechts-Universität zu Kiel Ulla Ohlms, Chairwoman, Patients' Tumor Bank of Hop (PATH) Prof. Tade Matthias Spranger, Head of a BMBF Research Griup, University of Bonn |
| 03:30p.m. | Coffee Break, Networking & Visit of the exhibition |
| 04:00p.m. | Project introduction: short presentations of selected innovative,.market-orientated projects that lead to products, technologies and services in the context of personalized medicine |
| 05:30p.m. | Summary of results, day 1 Chairman: Prof. Dr. Theo Dingermann, Chair for Pharmaceutical Biology, Goethe-University Frankfurt Speakers: Chairs of the Open Innovation Fora 1, 2 & 3 |
| 06:00p.m. | End of 1st Congress Day and Exhibition |
| 06:30p.m. | PerMediCon Executive Night |
* These workshops of the Open Innovation Forum are just held in German
